DE-THE-LYCRA-COMPANY
23.7.2024 11:01:35 CEST | Business Wire | Press release
The LYCRA Company, a global leader in developing innovative and sustainable fiber and technology solutions for the apparel and textile industry, has announced that its COOLMAX® EcoMade fiber made from 100% textile waste is a key ingredient in the Brazilian Volleyball team’s indoor and beach jerseys for the 2024 Summer Games in Paris. Body Work, a fitness brand from retailer Riachuelo, created the official uniforms unveiled in a stunning projection on the Christ the Redeemer statue overlooking Rio de Janeiro on June 27, Volleyball Day in Brazil.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716778680/en/
Body Work, a fitness brand from Riachuelo, has revealed the official Brazilian Volleyball team shirts for the 2024 Summer Games. The fabric blends two technologies from The LYCRA Company: 92% COOLMAX® EcoMade fiber made from pre-consumer textile waste and 8% LYCRA® fiber to help keep athletes cool, dry, and moving freely. (Photo: Business Wire)
COOLMAX® EcoMade fiber transports moisture away from the body to the surface of the fabric, where it evaporates. This helps athletes stay cool, dry, and comfortable so they can focus on the game. It is one of many innovative branded fibers produced by The LYCRA Company designed to help optimize athletic performance. This technology converts pre-consumer textile waste scraps from garment manufacturers into fibers offering comparable performance to virgin polyester.
“We are thrilled that Brazil’s volleyball uniforms feature 92% COOLMAX® EcoMade fiber made from textile waste and 8% LYCRA® fiber, so we will be rooting for them in Paris,” said Nicolas Banyols, chief commercial officer - apparel, The LYCRA Company. “The benefits of activewear and sportswear with performance fibers are not limited to elite athletes anymore. Consumers of all abilities can now buy these innovative garments at retail, ensuring that everyone can experience the enhanced comfort and performance our fibers offer, in addition to options for durable and sustainable fibers for reduced environmental impact.”
LYCRA® brand fibers, now owned by The LYCRA Company, have been an integral part of the games since 1968, when the French alpine ski team dominated the medal count in Grenoble. The team's ski suits featured LYCRA® fiber, which provided a second-skin fit and greater freedom of movement. The long-standing history of performance and innovation in sports is a testament to the trust and reliability that the company’s fibers offer, instilling confidence in athletes and consumers alike.
“While the silver medal-winning 1984 Brazilian volleyball team uniform was the main inspiration for the design of this jersey, we wanted the fabric to be cutting-edge and future-focused,” said Camila de Paula Souza, Style Manager at Body Work | Riachuelo. “This fabric is designed to provide comfort and is made from textile waste—a win for athletes and a win for the planet.”
Consumers may purchase the official Brazilian Volleyball Team shirts at riachuleo.com. For more information on COOLMAX® EcoMade fiber benefits, visit coolmax.com.
About The LYCRA Company
The LYCRA Company is a leading global fiber and technology solutions provider to the apparel and personal care industries committed to offering sustainable products using renewable, pre-, and post-consumer recycled ingredients that reduce waste and help set the stage for circularity. Headquartered in Wilmington, Delaware, United States, it owns the LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL® brands. The LYCRA Company adds value to its customers’ products by offering unique innovations that meet the consumer’s need for comfort and lasting performance. Learn more at lycra.com.
COOLMAX® and LYCRA® are trademarks of The LYCRA Company.
About Riachuelo
With over 75 years of history, Riachuelo operates with the purpose of connecting desires to achievements. By combining innovation, dynamism, and agility to deliver collections and products for all styles, the brand is a leading reference in the sector and is recognized as one of the largest fashion companies in Brazil. Riachuelo boasts more than 30 million cardholders and over 400 own stores across the country.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240716778680/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 15:30:00 CEST | Press release
Quaise's Project Obsidian, a commercial-scale superhot Enhanced Geothermal System (EGS), selected to receive federal funding as part of $99 million DOE effort to advance geothermal energy development across the United States Supports completion of the first well triplet at Project Obsidian, targeting more than 25 megawatts of gross electric power Project team includes Pacific Northwest National Laboratory, Lawrence Berkeley National Laboratory and Oregon State University Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country.
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 15:30:00 CEST | Press release
Late-Breaking Abstract to Feature New Data from First Phase 3 Registrational Study of Arcotatug Tavatecan in Previously Treated Advanced Gastric CancerTAK-928 Presentations Reinforce Potential in Patients with Immunotherapy-Resistant Non-Small Cell Lung Cancer (NSCLC) and Previously Untreated NSCLCTakeda Continues to Progress Clinical Development of Arcotatug Tavatecan and TAK-928; New Non-Squamous NSCLC Sub-Trial Added to Global Phase 3 MarsLight-11 Study Evaluating TAK-928 vs. Docetaxel Monotherapy Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be
From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 15:00:00 CEST | Press release
Colgate-Palmolive builds on its legacy of oral health, publishing an impact evaluation, evolving its health education tools rooted in behavior change, and scaling its global health partnerships. Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and
Citi Wealth’s 2026 Global Family Office Report Reveals Clients Are Shifting Their Focus Towards Public Equities While Becoming More Deliberate and Resilient Amid Uncertainty22.9.2026 14:30:00 CEST | Press release
Public equities have re-emerged as the primary destination for incremental capital Private markets remain a strategic pillar of family office portfolios Artificial intelligence is moving from experimentation toward implementation Cross-border complexity is rising as families become increasingly international Leadership succession and next-generation preparedness are now immediate priorities rather than distant considerations Watch Citi Wealth’s Global Family Office leadership discuss the report’s findings here. Citi Wealth today released its 2026 Global Family Office Report, offering an inside perspective into the thinking and behaviors of the world’s most sophisticated investors. The report was compiled by Citi Wealth’s Global Family Office Group, which works with more than 1,900 family offices worldwide. Conducted in June and July 2026, the survey sheds light on how over 350 family offices in more than 40 countries are navigating new complexities in an era defined by uncertainty. Tod
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio22.9.2026 14:30:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held September 30 - October 3, 2026, in Vienna, Austria. "The breadth of research being presented at EADV 2026 highlights the strength of our Inflammation and Autoimmunity portfolio," said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Data presentations in hidradenitis suppurativa, atopic dermatitis and prurigo nodularis demonstrate our commitment to advancing innovation across immune-mediated skin diseases and deepening our understanding of the patient experience." Details on key Incyte data presentations at EADV include: Oral Presentations Atopic Dermatitis Atopic Dermatitis and Life Course Disruption: Evidence From a Multidimensional International Survey (TOPiQAL) (Session: Free Communication 1: Atopic dermatitis/Eczema. Thursday, October 1, 2:50-3:0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom